Shattuck Labs, Inc. Ttl Fee Amt
Shattuck Labs, Inc. (STTK) had Ttl Fee Amt of $4.39 thousand as of 2026-08-10, per its S-8 filed 2026-08-11.
Financial Statements › Notes
ffd:TtlFeeAmt · last filed 2026-08-11
- 2026-08-10: Ttl Fee Amt $4.39K.
| Period end | Ttl Fee Amt |
|---|---|
| 2026-08-10 | $4.39K S-8 · filed 2026-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |